| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.smruthiorganics.com | |
| Market Cap | 147.03 Cr. | |
| Enterprise Value(EV) | 152.55 Cr. | 2022-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 4.45 | Trailing Twelve Months Ending 2022-12 |
| Price-Earning Ratio (PE) | 28.88 | Trailing Twelve Months Ending 2022-12 |
| Industry PE | 32.17 | Trailing Twelve Months Ending 2022-12 |
| Book Value / Share | 58.54 | Trailing Twelve Months Ending 2022-12 |
| Price to Book Value | 2.19 | Calculated using Price: 128.45 |
| Dividend Yield | 2.34 | Period Ending 2022-03 |
| No. of Shares Subscribed | 1.14 Cr. | 11,446,290 Shares |
| FaceValue | 10 | |
| Company Profile | ||
| Smruthi Organics Ltd is a mid-size, public limited, API manufacturing company from Solapur, India. Smruthi Organics Ltd was established in1989 by qualified technocrats and has very good experience and reputation in the pharmaceutical industry for the supply of quality products. | ||
| 1 Day |
|
-1.12% |
| 1 Week |
|
-0.78% |
| 1 Month |
|
+4.28% |
| 3 Month |
|
-26.65% |
| 6 Month |
|
-41.22% |
| 1 Year |
|
-45.68% |
| 2 Year |
|
-46.09% |
| 5 Year |
|
+287.88% |
| 10 Year |
|
+232.73% |
| 9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | -16.15 | -11.83 | 2.41 | 5.03 | -10.48 | 20.97 | 21.43 | 33.23 | 16.27 | |
| Return on Capital Employed (%) | -4.60 | -0.01 | 9.53 | 10.60 | -0.96 | 21.54 | 25.00 | 39.08 | 20.99 | |
| Return on Assets (%) | -4.83 | -3.27 | 0.69 | 1.69 | -3.79 | 7.42 | 8.96 | 19.05 | 11.57 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
| Shh. Funds | 35 | 29 | 31 | 32 | 29 | 36 | 42 | 60 | 67 | 67 | |
| Non Curr. Liab. | 32 | 34 | 32 | 11 | 7 | 7 | 7 | 5 | 5 | 4 | |
| Curr. Liab. | 58 | 44 | 39 | 42 | 48 | 57 | 38 | 26 | 15 | 34 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 126 | 107 | 102 | 85 | 84 | 101 | 88 | 92 | 88 | 105 | |
| Non Curr. Assets | 67 | 61 | 58 | 41 | 33 | 36 | 35 | 33 | 35 | 37 | |
| Curr. Assets | 59 | 47 | 44 | 44 | 51 | 65 | 53 | 59 | 52 | 69 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 126 | 107 | 102 | 85 | 84 | 101 | 88 | 92 | 88 | 105 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
| Net Sales | 94 | 77 | 74 | 79 | 97 | 137 | 131 | 127 | 133 | 140 | |
| Other Income | 1 | 0 | 0 | 1 | 0 | 1 | 4 | 1 | 1 | 0 | |
| Total Income | 94 | 77 | 74 | 80 | 98 | 138 | 136 | 127 | 134 | 140 | |
| Total Expenditure | -92 | -72 | -63 | -69 | -94 | -121 | -116 | -98 | -115 | -129 | |
| PBIDT | 2 | 5 | 11 | 11 | 3 | 17 | 20 | 29 | 19 | 11 | |
| Interest | -5 | -6 | -5 | -4 | -4 | -4 | -3 | -1 | -1 | -1 | |
| Depreciation | -6 | -5 | -4 | -4 | -4 | -4 | -4 | -4 | -4 | -4 | |
| Taxation | 3 | 2 | -1 | -1 | 1 | -3 | -4 | -7 | -3 | -1 | |
| Exceptional Items | |||||||||||
| PAT | -6 | -4 | 1 | 2 | -3 | 7 | 8 | 17 | 10 | 5 | |
| Adjusted EPS | -5 | -3 | 1 | 1 | -3 | 6 | 7 | 15 | 9 | 4 |
| Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 5 | 9 | 9 | 14 | 9 | 5 | 12 | 21 | 23 | 2 | |
| Cash Fr. Inv. | -13 | -2 | -1 | 0 | 0 | -3 | -5 | -5 | -3 | -6 | |
| Cash Fr. Finan. | 6 | -6 | -8 | -14 | -9 | -2 | -5 | -17 | -7 | -12 | |
| Net Change | -1 | 2 | -1 | 0 | 0 | 0 | 2 | -1 | 13 | -16 | |
| Cash & Cash Eqvt | 1 | 2 | 2 | 2 | 2 | 2 | 4 | 4 | 16 | 1 |
|
Fri, 10 Feb 2023
Intimation Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 We are pleased to inform you that our Companys Flagship API site has been successfully inspected by Ministry of Food and Drug Safety (MFDS) Republic of South Korea leading to the registration of our product in the Korean market. This positive outcome will enable the company to export its products to Republic of South Korea and several other signatory countries of the PIC/S scheme. |
|
Thu, 09 Feb 2023
Board Meeting Outcome for Outcome Of Board Meeting Of The Company Held Today I.E. Thursday 09Th February 2023. Kindly note that the Board of Directors of the Company has in its meeting held today i.e. on Thursday 09th February 2023 ("said meeting") considered and approved the Unaudited Financial Results of the Company for the third quarter ended 31st December 2022.Further pursuant to the applicable provisions of SEBI Listing Regulations please find enclosed herewith: - (i) the Unaudited Financial Results; and (ii) Limited Review Report dated 09th February 2023 issued by the Statutory Auditors of the Company w.r.t. the Unaudited Financial Results and taken on record by the Board of Directors of the Company. |
|
Thu, 09 Feb 2023
Unaudited Financial Results Of The Company For The Third Quarter Ended 31St December 2022. Kindly note that the Board of Directors of the Company has in its meeting held today i.e. on Thursday 09th February 2023 ("said meeting") considered and approved the Unaudited Financial Results of the Company for the third quarter ended 31st December 2022.Further pursuant to the applicable provisions of SEBI Listing Regulations please find enclosed herewith: - (i) the Unaudited Financial Results; and (ii) Limited Review Report dated 09th February 2023 issued by the Statutory Auditors of the Company w.r.t. the Unaudited Financial Results and taken on record by the Board of Directors of the Company. |
| Wed, 29 Mar 2023 |
High Delivery Percentage
|
Closing Below Previous Low
|
High Decrease in 3 Months
|
High Decrease in 6 Months
|
High Decrease in 1 Year
|
Equities
M.F.
Sectors